hexamethonium has been researched along with Hypertrophy in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
| Excerpt | Relevance | Reference |
|---|---|---|
| " At 16 weeks of age more-complete dose-response curves to the alpha 1-agonist methoxamine were also constructed." | 1.29 | Arterial hypertrophy and pressor responsiveness during development of hypertension in spontaneously hypertensive rats. ( Lee, RM; Leenen, FH; Tsoporis, J; Yuan, B, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leenen, FH | 1 |
| Yuan, B | 1 |
| Tsoporis, J | 1 |
| Lee, RM | 1 |
1 other study available for hexamethonium and Hypertrophy
| Article | Year |
|---|---|
Arterial hypertrophy and pressor responsiveness during development of hypertension in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Ganglionic Blockers; Heart Ventricles; Hemodynamics; Hexamethonium; Hexamet | 1994 |